Patent ID: 6998139

Claim:
An intrabucally quick disintegrating dosage form selected from the group consisting of: (a) a dry-coated tablet which comprises: (i) an outer layer comprising at least one saccharide and a water-insoluble pharmaceutically and/or coloring agent in the form of particles having an average particle size of 30 μm or less and in an amount of from 20 to 250 mg per tablet, and (ii) an inner layer or a core comprising a drug having a bitter taste and at least one saccharide, wherein said inner layer or said core is disposed at a position within said outer layer; (b) laminated or coated granules which comprise: (i) a core comprising a drug having a bitter taste and at least one saccharide, and (ii) an outer layer laminated or coated thereon and comprising at least one saccharide and a water-insoluble pharmaceutically acceptable pigment and/or coloring agent in the form of particles having an average particle size of 30 μm or less and in an amount of from 20 to 250 mg per dosage form, wherein said granules are or are not contained in a solid preparation; and (c) a three-layered tablet which comprises: an upper and lower layer, each comprising at least one saccharide and a water-insoluble pharmaceutically acceptable pigment and/or coloring agent in the form of particles having an average particle size of 30 μm or less and in an amount of from 20 to 250 mg per tablet, arranged on an intermediate layer which comprises a drug having a bitter taste and at least one saccharide, wherein when the dosage form is taken in the mouth, said water-insoluble pharmaceutically acceptable pigment and/or coloring agent is dispersed as particles and the dispersion of the particles starts 1 to 10 seconds prior to release of the drug having the bitter taste.